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Pleiotropic actions of miR-21 highlight the critical role
of deregulated stromal microRNAs during colorectal
cancer progression
MD Bullock*,1, KM Pickard1, BS Nielsen2, AE Sayan1, V Jenei1, M Mellone1, R Mitter3, JN Primrose1, GJ Thomas1,
GK Packham1 and AH Mirenzami1
The oncogene microRNA-21 (miRNA; miR-21) is overexpressed in most solid organ tumours; however, a recent examination of
stage II colorectal cancer (CRC) specimens suggests this may be a stromal phenomenon and not only a feature of cancer cells.
In vitro and in vivo studies show that miR-21 has potent pro-metastatic effects in various malignant carcinoma cell lines. The
tumour microenvironment has also been identified as a key actor during the metastatic cascade; however to date the
significance of deregulated miR-21 expression within the cancer-associated stroma has not been examined. In the present study,
a quantitative RT-PCR-based analysis of laser microdissected tissue confirmed that miR-21 expression is associated with a four-
fold mean increase in CRC stroma compared with normal tissue. In situ hybridisation using locked nucleic acid probes localised
miR-21 expression predominantly to fibroblasts within tumour-associated stroma. To study the molecular and biological impact
of deregulated stromal miR-21 in CRC, stable ectopic expression was induced in immortalised fibroblasts. This resulted in
upregulated a-smooth muscle actin expression implying miR-21 overexpression is driving the fibroblast-to-myofibroblast
transdifferentiation. Conditioned medium from miR-21-overexpressing fibroblasts protected CRC cells from oxaliplatin-induced
apoptosis and increased their proliferative capacity. 3D organotypic co-cultures containing fibroblasts and CRC cells revealed
that ectopic stromal miR-21 expression was associated with increased epithelial invasiveness. Reversion-inducing cysteine-rich
protein with kazal motifs, an inhibitor of matrix-remodelling enzyme MMP2, was significantly downregulated by ectopic miR-21 in
established and primary colorectal fibroblasts with a reciprocal rise in MMP2 activity. Inhibition of MMP2 abrogated the invasion-
promoting effects of ectopic miR-21. This data, which characterises a novel pro-metastatic mechanismmediated by miR-21 in the
CRC stroma, highlights the importance of miRNA deregulation within the tumour microenvironment and identifies a potential
application for stromal miRNAs as biomarkers in cancer.
Cell Death and Disease (2013) 4, e684; doi:10.1038/cddis.2013.213; published online 20 June 2013
Subject Category: Cancer
Colorectal cancer (CRC) is a key public health issue, and
accounts for the second highest cause of cancer-related
death in Western societies.1 Metastases are the principle
cause of death, and occur in 30% of patients at presentation
and subsequently in 450% of patients after surgery with
curative intent.2 The metastatic cascade is a complex,
multistep process3 and despite the introduction of che-
motherapy and newer targeted therapies, the majority of
patients with metastases remain incurable.4,5 An important
feature of metastatic progression is the role had by the
tumour microenvironment and the promotion of tumour
growth, invasion and angiogenesis by the cancer-
associated stroma.6,7 The key cellular components of
cancer-associated stroma are myofibroblasts, a-smooth
muscle actin (SMA)-expressing cells that transdifferentiate
from fibroblast progenitors in response to paracrine signals
from the malignant epithelium.6 These cells also modulate
the chemistry of the tumour microenvironment by producing
matrix metalloproteinase enzymes (MMPs), MMP inhibitors,
extracellular matrix (ECM) components, growth factors
and cytokines.8 The dynamic and reciprocal interaction
between stromal and malignant epithelial cells has a
profound impact on tumour progression in vivo,9 and as
stromal cells are less likely to acquire de novo mutations,
evade anti-cancer immunity or develop drug resistance, the
development of targeted therapies based on improved
1Cancer Sciences Division, University of Southampton, Somers Cancer Sciences Building, Southampton General Hospital, Tremona Road, Southampton, UK; 2Bioneer
A/S, Molecular Histology, Horsholm, Denmark and 3Bioinformatics Unit, London Research Institute, Cancer Research UK, London, UK
*Corresponding author: MD Bullock, Cancer Sciences Division, University of Southampton, Somers Cancer Sciences Building, Southampton General Hospital, Tremona
Road, Southampton SO16 6YD, UK. Tel: þ 44 (0)772 0896 567; Fax: þ 44 (0)238 0794 020; E-mail: m.bullock@soton.ac.uk
Received 10.4.13; revised 13.5.13; accepted 17.5.13; Edited by M Agostini
Keywords: colorectal neoplasia; neoplasm metastasis; stroma; MicroRNA; MiR-21
Abbreviations: miRNA (miR), microRNA; CRC, colorectal cancer; MMP, matrix metalloproteinase; ECM, extracellular matrix; PTEN, phosphate and tensin homologue;
PDCD4, programmed cell death 4; RECK, reversion-inducing cysteine-rich protein with kazal motifs; TGF-b, transforming growth factor beta; ISH, in situ hybridisation;
LNA, locked nucleic acid; LMD, laser microdissection; qPCR, quantitative PCR; SMA, smooth muscle actin; CM, conditioned medium; GFP, green fluorescent protein;
PCF, primary colon fibroblast; FFPE, formalin-fixed paraffin-embedded; DMEM, Dulbecco’s modified Eagle medium; FBS, foetal bovine serum; VIM, vimentin; CDH1,
E-Cadherin; S100A4 (FSP1), S100 calcium-binding protein A4 (fibroblast-specific protein 1)
Citation: Cell Death and Disease (2013) 4, e684; doi:10.1038/cddis.2013.213
& 2013 Macmillan Publishers Limited All rights reserved 2041-4889/13
www.nature.com/cddis
molecular characterisation of CRC stroma is an attractive
prospect.10,11
MicroRNAs (miRNAs) are a class of small highly conserved
non-coding RNAs that provide widespread expressional
control through repression of mRNA translation. They are
strongly implicated in the pathogenesis of numerous malig-
nancies,12 and hold promise as therapeutic targets as they
regulate fundamental intracellular processes and are deregu-
lated, often in a tissue- and tumour-specific manner, in all
cancer types examined to date.13
In CRC, miRNAs derail a number of cellular signal
transduction and cell survival pathways including the Wnt/b-
catenin pathway, epidermal growth factor receptor pathway
and p53 function connecting miRNA biology to known
mutational events in the classical adenoma–carcinoma
sequence of malignant transformation and potentially to each
of the hallmarks of cancer.14
High throughput profiling studies have also uncovered
miRNA-mediated pathways in the regulation of metastasis.
One miRNA with particular prominence is miRNA-21 (miR-
21), which in diverse cancer cell lines regulates apoptosis and
metastasis by suppressing genes such as phosphate and
tensin homologue (PTEN),15 programmed cell death 4
(PDCD4)16 and MMP inhibitors, reversion-inducing cysteine-
rich protein with Kazal motifs, (RECK) and tissue inhibitor of
metalloproteinase 3.17
Interestingly, Nielsen et al.18 recently demonstrated that
miR-21 overexpression in stage II CRC occurs in the stroma
rather than in the epithelium. In a separate study, miR-21
suppression with antisense inhibitors was shown to prevent
the fibroblast-to-myofibroblast transdifferentiation in response
to transforming growth factor beta (TGF-b).19 Together, these
data suggest that the pro-metastatic influence of miR-21 may
be mediated through the tumour microenvironment; however,
biological and functional evidence to support this model has
not been deeply investigated.
The aims of the current study are to provide multimodal
validation of miR-21 expression patterns in CRC and to gain
improved understanding of the pathological relevance of
deregulated stromal miR-21 by dissecting out molecular
interactions within the tumour microenvironment.
Results
MiR-21 expression localises to fibroblast-like cells in the
CRC stroma. Mir-21 has been shown to be upregulated in
different cancers including CRC.20–24 As most of these
studies utilised pieces of tumour tissue containing tumour
and non-tumour cells for the detection of miR-21 expression,
the relative contribution of stromal/cancers cells to the
observed miR-21 upregulation is not clearly established. To
identify the source of overexpressed miR-21 in CRC, we
used an in situ hybridisation (ISH) technique. Highly sensitive
locked nucleic acid (LNA) probes showed specific and
predominant staining in fibroblast-like cells in the stroma of
all CRC specimens examined. Crucially, tumour epithelium
and benign tissue showed only weak and sporadic expres-
sion of miR-21 in mononuclear cells (Figure 1a). To quantify
the overexpression of miR-21, we performed laser micro-
dissection (LMD; Figure 1b) followed by quantitative PCR
(qPCR) using TaqMan probes (Applied Biosystems, Foster
City, CA, USA). We found that mean miR-21 expression was
fourfold higher in the LMD stroma of CRC specimens compared
with paired normal tissue (P¼ 0.005, Figure 1c). To prove the
efficiency of LMD, we also conducted qPCR assays to quantify
expression of epithelial and mesenchymal markers in micro-
dissected tissue. Microdissected stroma expressed high levels
of mesenchymal cell-specific vimentin (VIM) mRNA and
fibroblast-specific protein 1 (FSP1; S100 calcium-binding
protein A4, S100A4; Po0.05) and low levels of epithelium-
specific E-Cadherin (CDH1; P¼ 0.05; Figure 1d).
The impact of stable ectopic miR-21 overexpression in
immortalised stromal fibroblasts. To assess the biological
significance of upregulated stromal miR-21, its ectopic
expression was stably induced in an established human
fibroblast cell line (MRC5). MiR-21-overexpressing MRC5
cells (MRC521) underwent striking morphological change,
adopting enlarged and elongated forms, which was accom-
panied by minor increases in a-SMA expression compared
with identical passage scrambled control-transfected
(MRC5SCC) cells (Figure 2a). Fibroblasts showing similar
morphological features are considered as myofibroblasts and
characterised by increased a-SMA containing intracellular
filaments. Secreted molecules from cancer cells such as
TGF-b are responsible for fibroblast-to-myofibroblast trans-
differentiation.8 Myofibroblasts are often observed in the
tumour microenvironment and their presence has been
proposed as an independent marker of poor prognosis.25
To assess whether miR-21 overexpression primes myofi-
broblast transdifferentiation or provokes an intermediate
differentiation state, MRC521 and MRCSCC cells were treated
with conditioned media (CM) extracted from SW480 CRC
cells (CMSW480) or TGF-b at 2 ng/ml or 10 ng/ml final
concentration, respectively. After 3 days, a-SMA expression
was assessed by immunofluorescence revealing that stress
fibre formation had occurred in a significantly greater
proportion of MRC521 cells than that of MRC5SCC cells in
response to CMSW480 and low dose TGF-b. As anticipated,
treatment with higher TGF-b doses induced large numbers of
both MRC5SCC and MRC521 cells to undergo myofibroblast
transdifferentiation. Stress fibre deposition was not found in
significant numbers of MRC521 or MRC5SCC cells in the
untreated group (Figure 2b).
These results suggest that although miR-21 expression
alone is insufficient to drive myofibroblast transdifferentiation,
it may condition/facilitate fibroblasts to acquire the myofibro-
blast state.
Medium supernatant from miR-21-overexpressing fibro-
blasts increases the proliferative capacity of CRC cells
and protects them from oxaliplatin-induced apoptosis.
The reciprocal interaction between cancer cells and tumour
stroma is a contributing factor in carcinoma progression. To
assess the effect of stromal miR-21 manipulation on the cell
fate of CRC cells, we investigated their proliferative properties
and resistance to apoptosis. After a 24- or 48-h incubation
with CM from MRC521 cells (CM21), the mean cell density of
SW480 cells increased by 40% (Po0.03) and 93% (P¼ 0.01)
compared with controls (CM from MRC5SCC; CMSCC),
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respectively. Under the same conditions, another CRC cell
line (DLD1) showed an 18% (t¼ 24h, P¼ 0.09) and 66%
(t¼ 48h, P¼ 0.01) mean cell density increase compared with
controls (Figure 3a).
We also evaluated the comparative effect of CM21 or
CMSCC treatment on oxaliplatin-mediated apoptosis. We
found that oxaliplatin, a first-line cytotoxic agent for the
treatment of patients with stage III and IV CRC, was
less effective at inducing apoptosis and cell death in CM21-
treated CRC cells compared with CMSCC-treated controls
(Figures 3b and c).
Medium supernatant from miR-21-overexpressing
fibroblasts enhances CRC cell invasion. Increased
motility and invasion are critical physiological processes in
the course of metastasis. To assess whether stromal miR-21
alters the invasive properties of CRC cells, we used CM from
miR-21 and miR-SCC stably transfected cells (CM21/CMSCC)
as chemoattractant and performed transwell invasion
assays. CM21 was associated with 1.7- (Po0.02) and 1.8-
fold (P¼ 0.03) increases in invasiveness of SW480 and
DLD1 CRC epithelial cells, respectively, compared with
CMSCC controls (Figure 4a). In order to examine invasive-
ness further, we used organotypic culture conditions that
closely resemble the in vivo tumour microenvironment. To
achieve this, we embedded MRC521 or MRC5SCC cells into
gels containing ECM components (matrigel and collagen)
and seeded CRC cells as a layer on the top. Our results
showed a 2.5-fold (Po0.005) increase in the invasion of
SW480 cells into the stroma containing MRC521 cells
compared with control (Figure 4b). Green fluorescent protein
(GFP)-positive cells within the stroma confirmed the pre-
sence of fibroblasts stably transfected with IRES-driven
miRNA/GFP co-expression plasmid (Figure 4c). These
results suggest that stromal expression of miR-21 can induce
enhanced motility and invasion of CRC cells.
MiR-21 targets RECK in the CRC stroma. To streamline
the search for mechanistic explanations for the novel
observation that miR-21 overexpression in fibroblasts
enhances CRC invasiveness, we turned our focus to a
regulator of ECM remodelling known to be targeted by
miR-21:17 RECK is a negative regulator of MMP activity.
RECK mRNA has been shown to be targeted directly by miR-
21 in mutated/unmutated 30-untranslated region luciferase
reporter assays in several cell lines and in numerous tumour
contexts.17,26 We found that stable miR-21-expressing
fibroblasts express reduced RECK mRNA and protein
Figure 1 (a) ISH of representative CRC and normal colonic tissue sections using LNA probes against miR-21. MiR-21 positivity is characterised by an intense blue
chromogenic reaction. (b) LMD was performed on fresh frozen human CRC specimens and paired normal tissue to isolate stroma from epithelial tissue. Cresyl violet staining
was used to highlight epithelium (i); the area of interest was then defined (ii) before laser dissection occurred (iii) and the cut piece was transported to a collection device (iv).
(c) High sensitivity TaqMan qPCR using total RNA extracted from LMD tissue of patients with CRC (n¼ 10) reveals that stromal miR-21 expression successfully separates
tumour from paired normal tissue. Absolute miR-21 expression values are displayed around the mean represented by a horizontal bar. (d) To prove the efficiency of LMD,
expression of mesenchymal cell-specific mRNA vimentin (VIM), FSP1 mRNA (S100A4), and epithelium-specific mRNA E-Cadherin (CDH1) were quantified in LMD stromal
and epithelial tissue (*Po0.05; **Po0.005)
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(Figures 5a and b). These results provide mechanistic
explanation why stromal expression of miR-21 is a contri-
buting factor to invasiveness of CRC tumours. In order to
validate the functional consequences of miR-21 expression
in relation to MMP activation, we stained sections of
organotypic cultures with RECK. We observed fibroblast-
specific expression of this protein in MRC5SCC but not
MRC521 specimens consistent with our previous findings that
MRC521-containing stroma significantly enhanced invasion
of SW480 CRC cells (Figure 5c).
Finally, to observe the relationship between miR-21 and its
target RECK in a more physiological setting, primary colon
fibroblasts (PCFs) were obtained and transiently transfected
with miR-21/GFP or miR-SCC/GFP co-expression plasmid.
After 48 h, transfection cells were fixed for the purpose of
immunofluorescence labelling. Cells transfected with
scrambled control plasmid demonstrated baseline RECK
expression. In contrast, miR-21-transfected cells displayed
decreased RECK expression in proportion with transfection
efficiency as cells exhibiting themost intenseGFP signal were
also associated with the most diminished RECK fluorescence
signal (Figure 5d).
MiR-21-dependent RECK downregulation is associated
with a reciprocal rise in MMP2 activity – CRC invasion is
MMP2 dependent. The key action of RECK is to inhibit the
otherwise unchecked activity of MMPs involved in the
breakdown of ECM. To assess whether RECK down-
regulation in response to ectopic miR-21 expression leads
to increased MMP activity, CM21 and CMSCC were analysed
by gelatin zymography. In this assay, a dominant band
corresponding to MMP2 was consistently detected and miR-
21 upregulation led to a significantly increased gelatinase
activity compared with controls (Figures 6a and b).
Importantly, the increased invasive effect associated with
CM21 compared with CMSCC in transwell assays was partially
abrogated in the presence of 25mMMMP2 inhibitor (Figure 6c),
suggesting stromal miR-21-dependent SW480 CRC cell
invasion is mediated in part by increased MMP2 activity.
Discussion
Targeted therapeutic strategies based on an improved
understanding of the molecular biology of malignancy have
been applied to CRC with little success;4,5 however, recent
Figure 2 Fluorescence from MRC5 fibroblasts stably transfected with miR-21/GFP or control miR-SCC/GFP co-expression plasmids highlight the morphological changes
associated with ectopic miR-21 expression in fibroblasts ( 40 magnification). Western blot analysis reveals that MRC5 fibroblasts in which miR-21 has been stably induced
express upregulated a-SMA compared with controls. (b) Immunofluorescence staining for a-SMA in MRC5 fibroblasts stably expressing either miR-21 or miR-SCC at  40
magnification: MiR-21 but not miR-SCC is associated with a-SMA stress fibres formation, following treatment with low doses of TGF-b (2 ng/ml) or culture medium extracted
from SW480 CRC cells (CMSW480). High doses of TGF-b (10 ng/ml) also induce stress fibre deposition in miR-SCC-transfected cells, which serves as a positive control
(*Po0.05; **Po0.005)
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insights linking deregulated miRNA expression to malignant
change16,27 and to the acquisition of metastatic capabil-
ities17,28–31 have brought renewed optimism. Although can-
cer-associated stroma is an attractive target for novel drug
development, researchers have focused mainly on deregu-
latedmiRNAs in cancer epithelial cells, and as a consequence
the identity and the role of stromal miRNAs remains poorly
understood.
Nevertheless, recent studies have provided valuable
insights: Bronisz et al.32 powerfully demonstrated that down-
regulation of miR-320 in mammary stromal fibroblasts
reprograms the tumour microenvironment by activating a
pro-oncogenic secretome; and Yao et al.19 demonstrated that
myofibroblast transdifferentiation from progenitor fibroblasts
in response to TGF-b could be prevented using specific
antisense inhibitors of miR-21. The implications of these data,
which suggest a regulatory role for miRNAs in fibroblast
differentiation and phenotype, are potentially profound as
cancer-associated fibroblasts, including myofibroblasts, are
powerful regulators of invasive cancer growth, angiogenesis
and disease progression (reviewed by De Wever et al.8).
Studies of various solid organ tumours have linked elevated
miR-21 expression to advancing tumour stage, venous
invasion, lymph node and distant metastases, poor disease-
free survival and poor overall survival.33,34 In CRC cell lines,
miR-21 correlates inversely with target protein PDCD4
expression, and anti-miR-21 reduces invasiveness and
capacity to form metastases in chicken-embryo-metastasis
assays.16 MiR-21 upregulation enhances proliferation in
pancreatic, glioblastoma and CRC cell lines,20–22 and as a
known anti-apoptotic factor23 it promotes resistance to radio-
therapy and chemotherapy in several tumour contexts.24
Crucially however, the chemoresistance and pro-metastatic
functions attributed to miR-21 are all mediated by the
malignant epithelium.
In the present study, we used high sensitivity TaqMan qPCR
assays to demonstrate that upregulated miR-21 expression
occurs not in CRC cells but in the cancer-associated stroma.
Furthermore, ISH pinpointed miR-21 overexpression exclu-
sively to fibroblast-like cells. Prompted by these results,
analysis of upregulated miR-21 expression in the stroma
became an important priority. Themost striking effect of stable
miR-21 expression in MRC5 fibroblasts was the adoption of an
elongated and enlarged morphology, accompanied by a minor
increase in a-SMA expression. Although suggestive of
myofibroblast differentiation status, in the absence of signi-
ficant stress fibre deposition, it was essential to conclude that
miR-21 overexpression alone is insufficient to drive fibroblast-
to-myofibroblast transdifferentiation.
Nevertheless, fibroblasts in which miR-21 had been
ectopically expressed did share a number of tumour-promot-
ing characteristics with myofibroblasts. Treatment with CM21
was associated with increased proliferation and reduced
oxaliplatin-induced apoptosis in CRC cell lines. CM21 was also
associated with increased CRC cell invasiveness in in vitro
transwell invasion assays and organotypic models.
To characterise the mechanism underlying this novel pro-
invasive effect, we turned our attention to regulators of ECM
remodelling known to be targeted by miR-21. RECK has been
shown to be targeted by miR-21 in glioma models, and as a
Figure 3 (a) Cell proliferation and viability assay of SW480 and DLD1 CRC cells following treatment with CM21 or CMSCC. Results represent mean cell density±S.E.M.
after 24 or 48 h incubation, from experiments repeated in triplicate. (b) Analysis of apoptosis in SW480 CRC cells pre-treated with CM21 or CMSCC in the presence or absence
of oxaliplatin at 30mg/ml. Columns represent percentage of live (AV /PI ), early apoptotic (AVþ /PI ) and late apoptotic (AVþ /PIþ ) cells in each treatment group.
Data presented represents results from three independent experiments expressed as means±S.E.M. (c) Representative FACS plot indicating the quadrants used to calculate
the proportion of live and apoptotic cells in b. (*Pr0.05)
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negative regulator of MMP activity it inhibits tumour
invasion.17 RECK is downregulated in the majority of CRC
specimens compared with normal tissue, and low expression
is associated with poor outcome.35 It is amembrane anchored
glycoprotein and its main function is to inhibit MMP2, MMP9
and MT1-MMP activity.36
In this study, we demonstrated that miR-21 negatively
regulates RECK protein expression in cultured and PCFs
transfected with a miR-21/GFP co-expression plasmid.
RECK is known to regulate MMP2 via a number of post-
transcriptional mechanisms and has a role in other cancer
relevant biological pathways.37 We demonstrated that ecto-
pic miR-21 expression in MRC5 fibroblasts increases MMP2
activity and by using specific inhibitors to show invasion by
SW480 CRC cells is MMP2 dependent, we highlighted a
possible mechanism through which upregulated stromal
miR-21 expression increases invasion in vitro. In cardiac
fibroblasts, miR-21-induced MMP2 upregulation is asso-
ciated with a PTEN-dependent mechanism,38 and although
PTEN is also a miR-21 target, we have focussed on an
alternative mechanism because in vivo MMP2 and RECK
expression are inversely correlated and have prognostic
relevance in CRC.39
A description of our major findings is provided in Figure 7. In
summary, we confirm that deregulation of the key oncomiR,
miR-21, is a stromal phenomenon in CRC. Our data also
shows that ectopic miR-21 expression in cultured fibroblasts
modulates the cytotoxic impact of oxaliplatin, promotes CRC
proliferation and enhances epithelial invasion. Changes in cell
morphology and increased a-SMA expression were observed
in the immortalised MRC521 fibroblasts but not control cells
(MRC5SCC). MRC521 fibroblasts also underwent myofibro-
blast transdifferentiation more readily in response to TGF-b
than control cells, suggesting that the functional impact of
stromal miR-21 on the hallmark processes of tumour
progression may be linked to the myofibroblast phenotype.
Furthermore, ectopic miR-21 expression in fibroblasts
resulted in downregulated RECK expression and increased
MMP2 activity.
This study highlights the importance of the stroma in CRC
progression and presents an interesting perspective for the
development of novel, stroma-targeted drugs.
Materials and Methods
Patients and samples. Samples from patients with biopsy-proven CRC
(tumour tissue and uninvolved proximal mucosa) were obtained fresh at the time
Figure 4 (a) CM21 when used as chemoattractant in in vitro transwell invasion assays is associated with increased invasiveness in CRC cell lines (SW480 and DLD1)
compared with control (CMSCC). Data presented represents results from three independent experiments (mean±S.E.M.; *Po0.05). (b) Representative sections of
organotypic co-culture models containing MRC521 and MRC5SCC cells within the stroma. Immunohistochemical staining with anti-pan-Cytokeratin antibody highlights
malignant epithelial SW480 CRC cells. The invasion index is increased 2.5-fold in the presence of MRC521 cells compared with control-transfected MRC5SCC cells
(mean±S.E.M. from triplicate repeats; **Po0.005). (c) Staining for GFP, which is co-expressed by miR-21 and miR-SCC plasmids, confirms the presence of stably
transfected fibroblasts within the stroma. GFP positivity is characterised by a brown chromogenic reaction
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of surgery and snap frozen in liquid nitrogen before being deposited in a
designated UK Human Tissue Act-approved tumour bank. All patients provided
informed consent in accordance with the Helsinki protocol and the study was
approved by the regional research ethics committee. Pathological verification of
diagnosis and staging was in accordance with the Association of Coloproctology of
Great Britain and Ireland guidelines on the management of CRC.
Ten adenocarcinomas, with a priori decided tumour stage (five Dukes A and five
Dukes C) and their paired uninvolved proximal mucosa were selected at random
before LMD and RNA extraction.
LMD and RNA extraction. Frozen human tissue specimens were sectioned
to 10-mm-thickness onto membrane-mounted slides (Molecular Devices, Sunnyvale,
CA, USA). Sections were fixed in 75% ethanol, stained with 1% Cresyl Violet
(Sigma, Dorset, UK) and dehydrated with increasing concentrations of ethanol before
being air dried. LMD was performed using the Leica AS microdissection platform
(Leica Microsystems, Milton Keynes, UK; Figure 1b) and cut stroma was collected
directly into 50ml cell lysis buffer (RNAqueous Micro Kit, Applied Biosystems). Total
RNA was extracted using the RNAqueous Micro Kit (Applied Biosystems).
TaqMan qPCR quantitation. Singleplex TaqMan miRNA assay reactions
were performed to quantitate miR-21 expression in all 10 tumour samples. For
each PCR assay, 2.5 ng of total RNA from LMD samples (0.5 ng/ml) was
converted into cDNA using a miRNA-specific reverse transcription step according
to the manufacturer’s instructions (Applied Biosystems). PCR reactions were set
Figure 5 MiR-21 upregulation in MRC5 fibroblasts leads to downregulated expression of MMP inhibitor RECK. (a) Western blot and (b) TaqMan qPCR analysis for RECK
protein and mRNA expression in MRC521 and MRC5SCC cells; *represents the mean±S.E.M. of four independent repeat experiments; Po0.05. (c) Representative sections
of organotypic stroma containing MRC521 or MRC5SCC cells immunostained with anti-RECK antibody. Positive brown cytoplasmic staining in stroma (indicated with arrows)
containing MRC5SCC fibroblasts contrasts with scant RECK expression in stroma containing MRC521 cells. (d) Immunofluorescence staining for RECK in ex vivo PCFs
transfected with either a miR-21/GFP or miR-SCC/GFP co-expression plasmid at  40 magnification
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up in triplicate using miR-21-specific primers and probes and 2 Universal PCR
Master Mix (Applied Biosystems), and performed using the ABI 7500 qPCR
instrument and the following cycling parameters: 95 1C for 10min, 40 cycles of
95 1C for 15 s and 60 oC for 60 s. Expression levels were normalised to U6 snRNA,
calculated from the triplicate of CT values using the DDCT method and expressed
relative to one of the specimens that was assigned the value 1.
U6B was selected as the endogenous reference gene for the purpose of miRNA
validation. Mean triplicate U6B snRNA expression was quantified by the 2DDCT,
allowing expression of miR-21 to be calculated relative to this reference. Mean
relative quantities were calculated for each paired tumour and normal tissue sample
and a paired Student’s t–test was performed to compare groups.
To quantify expression of epithelial and mesenchymal markers in LMD tissue,
25 ng of total RNA from the stroma or epithelium of a tumour specimen was
converted to cDNA.
Subsequently, PCR reactions were set up in triplicate using specific TaqMan
primers and probes for CDH1 (HS01023894_ML) VIM (HS00185584_ML), S100A4
(S100A4; HS00243202_ML) and 2 Universal PCR Master Mix, and performed
using the ABI 7500 qPCR instrument and the following cycling parameters: 95 1C for
10min, 40 cycles of 95 1C for 15 s and 60 1C for 60 s.
In situ hybridisation. ISH was performed as previously described.18
formalin-fixed paraffin-embedded (FFPE) CRC tissue sections (6mm) were
mounted on slides and placed in a Tecan Freedom Evo automated hybridisation
instrument (Tecan, Ma¨nnedorf, Switzerland) in which the following steps were
performed: proteinase-K treatment using 15 mg/ml for 8min at 37 1C, pre-
hybridisation for 15min at 57 1C, hybridisation for 60min at 57 1C with double DIG-
labelled miRCURY LNA probes (Exiqon, Vedbaek, Denmark) for miR-21 and a
scramble sequence (both at 40 nM), stringent washes with SSC buffers, DIG
blocking reagent (Roche, Mannheim, Germany), alkaline phosphatase-conjugated
anti-DIG (Roche), enzymatic development using NBT-BCIP substrate (Roche) for
60min and finally nuclear fast red counterstain (Vector Laboratories, Burlingame,
CA, USA).
Cell culture and transfections. Human CRC cell lines, SW480 and DLD1,
and MRC5 lung fibroblast cell were purchased from the European Collection of
Cell Culture (Salisbury, UK). Primary colonic fibroblasts were isolated and cultured
as described previously.25 Cells were maintained at 37 1C in a humidified
atmosphere of 5% CO2 in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% foetal bovine serum (FBS) and 2mM L-Glutamine.
Stable miR-21 and scrambled control (miR-SCC) miRNA expression in MRC5
fibroblasts (referred to as MRC521 and MRC5SCC cells, respectively) was achieved
by transfecting precursor miRNA expression plasmids containing an IRES-driven
GFP reporter and selected with puromycin (Genecopoeia, Rockville, MD, USA).
PCFs were transiently transfected with miR-21 or miR-SCC plasmid by the same
method. All transfections were performed using Xfect transfection reagent (Clontech
Laboratories, Mountain View, CA, USA).
Triplicate organotypic models were prepared as previously described.40 Briefly,
5 105 MRC521 or MRC5SCC cells were co-cultured with SW480 CRC cells for
14 days before harvest and fixation in formalin. Paraffin-embedded sections were
immunostained with anti-cytokeratin antibody to highlight CRC cells or anti-GFP
antibody to highlight stably transfected fibroblasts. The middle section of each gel was
imaged at  100 magnification for the purpose of quantitation of invasion. Quantitation
was achieved using Image-J image analysis software (NIH), measuring the number and
area of invading tumour islands to produce a modified ‘Invasion Index.’41
Cell lysis, SDS-PAGE and western blotting. Cells were lysed in 1
radioimmunoprecipitation buffer (150mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, 50mM Tris Cl pH 7.5) in the presence of protease
inhibitors (Roche). Proteins were separated under reducing conditions in 10%
SDS-PAGE gels, transferred onto nitrocellulose membrane, detected with anti-
RECK (Abgent, San Diego, CA, USA; AP9259c) or anti-SMA (Sigma; clone 1A4),
primary antibodies and horseradish peroxidase-conjugated (Dako, Glostrup,
Denmark) secondary antibody. Specific signal was visualised using Supersignal
West Pico Chemiluminescent detection kit (Thermo Scientific, Rockford, IL, USA),
and band intensity was quantified by densitometry using Image-J. Blots were
probed for Hsc-70 or b-actin (Santa Cruz Biotechnology, Dallas, TX, USA) as
loading controls.
Cell proliferation and viability assay. CM21/CMSCC were used to treat
DLD1 or SW480 CRC cells plated in triplicate at a density of 5000 per well of
a 96-well plate. Cell proliferation was measured using the CellTiter 96AQueous
One solution Cell Proliferation Assay (Promega, Madison, WI, USA), according to
the manufacturer’s instructions. Cell viability was assessed using 5 ml of MTS
Figure 6 Ectopic miR-21 expression in MRC5 fibroblasts leads to upregulated
MMP2 activity – SW480 CRC cell invasion is MMP2 dependent. (a) Representative
experiment showing zymographic activity in CM21 or CMSCC, with and without
MMP2 inhibitor (MMP2inh). (b) Assessment of MMP2 activity by determination of
zymographical band intensity. Results are expressed as a ratio of MMP2 activity in
CM21 compared with CMSCC in three independent experiments. (c) Transwell
invasion assay using CM21 or CMSCC as chemoattractant, with and without MMP2
inhibitor. Results represent the mean number of invading cells from four repeat
experiments (*Po0.05)
Figure 7 Proposed impact of deregulated miR-21 expression in CRC-
associated stroma. Reciprocal signalling between stromal and epithelial cells (thin
black arrows; left panel) is essential for normal colonic tissue homoeostasis. Early in
cancer, this process is corrupted and secreted factors from transformed epithelial
cells (dotted black arrow; central panel) initiate profound changes in adjacent
stromal cells. Upregulated miR-21 expression in stromal fibroblasts supports TGF-
b-dependent fibroblast-to-myofibroblast transdifferentiation (thick black arrow) and
causes downregulated RECK expression. Myofibroblast-derived factors are
important mediators of tumour progression (dotted red arrow; right panel), and
although in the absence of TGF-b, miR-21 is not sufficient to initiate myofibroblast
transdifferentiation, upregulated miR-21 does promote tumour proliferation
and chemoresistance and enhanced tumour invasion through upregulated
MMP2 activity
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solution per well, 24 and 48 h after seeding cells. Absorbance readings at 490 nm
were taken in triplicate using a spectrophotometric plate reader (Thermo Scientific,
Waltham, MA, USA).
Transwell invasion assay. Cell invasion assays were performed over 72 h,
as previously described,25 using CM21 and CMSCC supplemented with FBS as
chemoattractant. Cells invading the lower chamber were trypsinised and counted using
a Casy Cell Counter (Roche Innovatis, Bielefeld, Germany). Specific MMP2 inhibitor I
(Merck, Hoddesdon, UK), prepared at a stock concentration of 10mM in DMSO was
also added to the chemoattractant at a final concentration of 25mM, which achieved
maximal inhibition of invasion with no cytotoxic effects (data not shown).
Apoptosis assay. SW480 CRC cells (1 105) were plated overnight, in
complete DMEM in triplicate wells of a 24-well plate. After 24 h, SW480 cells were
washed three times with PBS and treated with 1ml of CM21 or CMSCC. A further
24 h later, cells were washed and treated either with complete DMEM containing
30mg/ml Oxaliplatin (Sigma, UK) or unmodified complete DMEM.
Apoptosis was examined using the Annexin V (Ann)/PI double staining method
(BD Bioscience, San Jose, CA, USA). Twenty four hours after treatment (oxaliplatin
or mock), SW480 cells were trypsinised without washing, resuspended in 300ml
1 binding buffer (10mM HEPES, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2), pooled
and double stained with 2.5ml Annexin V-FITC (BD Bioscience) and 2.5ml PI
(50mg/ml). Ten thousand events were acquired per sample using a FACS Canto
Flow Cytometer (BD Bioscience). The assay was repeated three times. Results are
presented as the percentage of total cells that are viable (Ann /PI ), early
apoptotic (Annþ /PI ) or late apoptotic (Annþ /PIþ ).
Gelatin zymography. CM21 and CMSCC were prepared in non-reducing 2
SDS sample buffer and loaded without boiling to a 10% polyacrylamide gel
copolymerised with 1 mg/ml of gelatin. Gels were washed twice for 30min in 2.5%
Triton X-100 (Sigma) to remove SDS and incubated in developing buffer (50mM
Tris-HCl, 0.2 M NaCl, 5 mM CaCl2 and 0.02% Triton X-100) at 37 1C overnight.
Gels were then stained for 30min (0.5% Coomassie blue, 30% MeOH, 10% glacial
acetic acid) before de-staining (30% MeOH, 10% glacial acetic acid). Gelatin-
degrading enzymes were identified as clear bands against the dark background of
the gel.
To validate the activity of miR-21 on MMP inhibition, MMP2 inhibitor I (Merck)
was either added at a final concentration of 25 mM to CM21/CMSCC for 1 h before
fractionation or to developing buffer following fractionation. Images of gels were
captured using a UVP Imagestore 5000 (Ultra-Violet Products, Cambridge, UK) and
band intensity quantified by Image-J. Results were expressed as relative changes in
MMP activity against the scrambled control-transfected cells.
Immunohistochemistry. A monoclonal anti-pan-Cytokeratin antibody
(Sigma) and Alexa Fluor 488 conjugate anti-GFP antibody (Invitrogen, Carlsbad,
CA, USA) were used for immunohistochemistry on FFPE organotypic sections.
Briefly, sections were mounted on APES-coated slides and dried for 24 h at 37 oC,
and then dewaxed and rehydrated. Endogenous peroxidase was blocked for
10min with 0.5% hydrogen peroxidase in methanol. Antigen retrieval was
conducted by incubating the sections with protease (Sigma) for 10min. Anti-pan-
Cytokeratin antibody was applied in TBS (pH 7.6) overnight at 4 1C. Swine anti-
rabbit IgG-biotinylated secondary antibody (Dako) was applied for 30min, followed
by peroxidase-labelled avidin–biotin complex (Vectastain Elite ABC Reagent,
Vector Laboratories) for 30min. Slides were washed three times with TBS
between applications. Positive staining was visualised using DABþ (Dako) for
5min counterstained in Mayer’s haematoxylin.
Immunofluorescence. Transiently transfected PCF (PCF21 and PCFSCC)
cells (5 104) were seeded in 12 wells onto 19mm circular coverslips sterilised in
100% ethanol. After 12 h, cells were fixed in 4% paraformaldehyde for 15min,
washed three times in PBS-Triton (0.1% Triton X-100) and incubated for 30min in
3% BSA diluted in PBS-Triton. Primary anti-RECK antibody (1/100 dilution)
incubation was performed at 4 1C overnight in a humidified box. The coverslips,
then, were washed three times in PBS-Triton and incubated with Alexa Fluor 546-
conjugated secondary antibody (1/500) for 1 h at room temperature. Finally,
coverslips were mounted onto glass slides using Vectashield Hardset mounting
media with DAPI and imaged using an Olympus IX81 fluorescence microscope
(Olympus, Southend-on-Sea, UK). Similar methodology was used to assess
a-SMA expression in MRC521 and MRC5SCC fibroblasts. Briefly, fibroblasts were
treated with complete DMEM or medium extracted from SW480 CRC cells
cultured overnight in DMEM (CMSW480), or TGF-b1 (R&D Systems, Minneapolis,
MN, USA) at final concentrations of 2 ng/ml or 10 ng/ml. Seventy-two hours later,
cells were stained using anti-SMA primary antibody, counterstained and imaged.
An Image-J program-based system was used for the identification and
quantification of stress fibres. Briefly, the stress fibres were identified by drawing
diagonal lines (n¼ 3) along the images and counting sudden and sharp increases
in red fluorescence intensity marking individual fibres along the lines.
Statistical analysis. Parametric and non-parametric statistics were
expressed as mean±S.E.M. from multiple experiments. Statistical analysis of
paired observations was conducted using Student’s t-test or Mann–Whitney
U-test. The threshold level of significance was set to 0.05 for all statistical tests.
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